epocrates logo
epocrates logo
epocrates logo
  • 0

Tables

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account
Browse:
Tables

ACLS: Asystole/PEA

(Circulation 2025)

1) Begin CPR

[follow BLS algorithm]
Info: use supplemental oxygen if available; attach cardiac monitor/defibrillator when available; do not delay CPR

2) Evaluate Rhythm

[confirm non-shockable asystole/PEA]
Info: ensure all leads/wires connected and ECG size not minimized

3) Resume CPR Immediately x2min

[start with compressions]
Info: use 30:2 ratio compressions to ventilations, each breath over 1sec with visible chest rise; consider advanced airway device if bag-valve-mask ventilations do not result in visible chest rise, confirm airway placement using 2 methods (consider waveform capnography) and secure, then ventilate 10 breaths/min (avoid hyperventilating), do not pause compressions for ventilations; establish IV/IO access ASAP; consider central access if IV/IO access unobtainable

4) Give Epinephrine During CPR

[epinephrine]
Dose: 1 mg (10 mL of 0.1 mg per mL solution) IV/IO q3-5min prn

5) Evaluate Rhythm

[confirm non-shockable asystole/PEA]
Info: assess AFTER 2min (5 cycles) of CPR; ensure all leads/wires connected and ECG size not minimized; if rhythm becomes shockable at any time, see ACLS: VF/Pulseless VT Table

6) Resume CPR Immediately x2min

[start with compressions]
Info: repeat 5 cycles (2min) CPR and q2min rhythm checks

7) Treat Reversible Causes

[5H's]
hypovolemia, hypoxia, hydrogen ion (acidosis), hypo/hyperkalemia, hypothermia
[5T's]
tension pneumothorax, tamponade (cardiac), toxins, thrombosis (pulmonary), thrombosis (coronary)

8) Optimization and Prognostication

[optimization]
Info: if available, quantitative waveform capnography, arterial diastolic pressure, and central venous oxygen saturation may be used to optimize CPR efforts
[prognostication]
Info: if intubated patient unable to achieve ETCO2 >10 mm Hg via waveform capnography after CPR x20min, may be used in decision to terminate resuscitation, but should not be single deciding factor
Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information